Embecta (EMBC) Other Non-Current Assets (2021 - 2022)

Embecta (EMBC) posted Other Non-Current Assets of $68.5 million for Q2 2022, up 312.65% sequentially from $16.6 million in Q1 2022.

Embecta (EMBC) Other Non-Current Assets (2021 - 2022) Analysis & Trends

Embecta has reported Other Non-Current Assets for 2 years, with the latest figure at $68.5 million in Q2 2022.

Quarterly Other Non-Current Assets changed N/A year-over-year to $68.5 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $68.5 million (changed N/A YoY) and the FY2021 annual result came in at $11.3 million, changed N/A from the prior year.
Other Non-Current Assets grew to $68.5 million in Q2 2022 per EMBC's latest filing, from $16.6 million in the prior quarter.
Over five years, Other Non-Current Assets peaked at $68.5 million in Q2 2022 and troughed at $11.2 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	2.55 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	434.00 Mn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	457.39 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	22.91 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	82.80 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	904.00 Mn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	672.80 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	669.00 Mn
10	Embecta	305.26 Mn	87.06 Mn	153.30 Mn	-

Download Data